BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of over 1000 found
  Current Search:  drug: 36753     

HTML
100%
Cancer Drug Avastin's Quality, Price Questioned
Cancer drug Avastin is found to cost more than it should, taking into consideration the fact that it doesn't significantly improve quality of life or prolong.

Avastin or bevacizumab is a drug made by Genentech.

It is already...

EMax Health:  Jul 8 2008 11:38PM
Matching: drug
Find similar documents
HTML
100%
FDA News Release: FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs
FDA NEWS RELEASE FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs Seeks to Strengthen Warnings Concerning Increased Risk of Tendinitis and Tendon Rupture The U.S.

Food and Drug Administration (FDA) has...

Macro World Investor:  Jul 9 2008 12:26AM
Matching: drug
Find similar documents
HTML
100%
FDA News Release: FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs
PM FDA NEWS RELEASE FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs Seeks to Strengthen Warnings Concerning Increased Risk of Tendinitis and Tendon Rupture The U.S.

Food and Drug Administration (FDA) has...

Calibre Macro World:  Jul 8 2008 10:38PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

KLFY:  Jul 8 2008 11:15PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

TickerTech.com:  Jul 9 2008 12:29AM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

PR Newswire via Yahoo!:  Jul 8 2008 11:40PM
Matching: drug
Find similar documents
HTML
100%
Elderly May Fare Worse On Prostate Cancer Drugs
CHICAGO (AP) A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn't spread.

In fact, men given the ...

CBS 2 Chicago:  Jul 9 2008 1:17AM
Matching: drug
Find similar documents
HTML
100%
Asia in the nano race
Though the nanotechnology race began well in the 1980s with the European Union (EU) aggressively pursuing nanomaterial-based research and development, it actually heated up with the launch of the National Nanotech Initiative by the Clinton...
Bio Spectrum Asia:  Jul 8 2008 5:37AM
Matching: drug
Find similar documents
HTML
100%
Effects of Methamphetamine Detected in Brain
A 10-day supply of methamphetamine depressed key regions of the brain that govern movement and planning as well as motivational behavior.

Receiving the drug again gets these quiescent chemicals working once more, suggesting that ...

Neurology Today:  Jul 8 2008 2:35PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for The Treatment of Osteo
SAN MARINO, Calif., July 8 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

NewsBlaze:  Jul 8 2008 8:56PM
Matching: drug
Find similar documents
HTML
100%
FDA Wants Suicide Warnings On Epilepsy Drugs
Regulatory Affairs / Drug Approvals News Featured Article Main Category: Regulatory Affairs / Drug Approvals Also Included In: Epilepsy; Psychology / Psychiatry; Pain / Anesthetics email to a friend printer friendly view / write...
Medical News Today:  Jul 8 2008 10:57AM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

San Francisco Business Times:  Jul 8 2008 9:08PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

San Antonio Business Journal:  Jul 8 2008 9:05PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Nashville Business Journal:  Jul 8 2008 9:02PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

The Business Journal Phoenix:  Jul 8 2008 8:57PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Columbus Business First:  Jul 8 2008 8:51PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Portland Business Journal:  Jul 8 2008 8:50PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Business Journal of Milwaukee:  Jul 8 2008 8:50PM
Matching: drug
Find similar documents
HTML
100%
FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs
The FDA has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling concerning the increased risk of tendinitis and tendon rupture is necessary.

Through its new authority under the...

PharmaceuticalProcessing:  Jul 8 2008 8:24PM
Matching: drug
Find similar documents
HTML
100%
FDA Requests Boxed Warnings on Fluoroquinolone Antimicrobial Drugs
Media Inquiries: Christopher Kelly, 301-827-6242 Consumer Inquiries: 888-INFO-FDA The U.S.

Food and Drug Administration (FDA) has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product...

FDA:  Jul 8 2008 6:02PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Cincinnati Business Journal:  Jul 8 2008 8:54PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Biz Journals:  Jul 8 2008 8:40PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 CA-Epeius-Biotechnol SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug...

Earthtimes.org:  Jul 8 2008 8:40PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

Yahoo! Canada:  Jul 8 2008 8:36PM
Matching: drug
Find similar documents
HTML
100%
Epeius Biotechnologies' Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteo
SAN MARINO, Calif., July 8 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Rexin-G has been granted Orphan Drug Designation by the U.S.

Food and Drug Administration (FDA) for the treatment of...

PR Newswire:  Jul 8 2008 8:33PM
Matching: drug
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.